The major mutation among these mutations is the promoter mutation in the gene encoding telomerase reverse transcriptase (TERT), which occurs at a frequency of 70–80% in bladder cancer patients [22–25]. The gene discussed is TERT; the disease is urinary bladder carcinoma.